Benoît Funalot

Benoît Funalot

Auto-generated profile, based on publicly available information

Benoît Funalot

Department of Genetics, IHU Necker-Enfants Malades, University Paris Descartes, 75015 Paris, France; Department of Genetics, GHU Henri Mondor, 94010 Créteil, France

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
LKLaura S. Kremer
Laura S. Kremer
DBDaniel M. Bader
Daniel M. Bader
CMChristian Mertes
Christian Mertes
RKRobert Kopajtich
Robert Kopajtich
GPGarwin Pichler
Garwin Pichler
PHProkisch Holger
Prokisch Holger
Across a variety of Mendelian disorders, ∼50–75% of patients do not receive a genetic diagnosis by exome sequencing indicating disease-causing variants in non-coding regions. Although genome sequencing in principle reveals all genetic variants, their sizeable number and poorer annotation make prioritization challenging. Here, we demonstrate the power of transcriptome sequencing to molecularly diagnose 10% (5 of 48) of mitochondriopathy patients and identify candidate genes for the remainder. We find a median of one aberrantly expressed gene, five aberrant splicing events and six mono-allelically expressed rare variants in patient-derived fibroblasts and establish disease-causing roles for each kind. Private exons often arise from cryptic splice sites providing an important clue for variant prioritization. One such event is found in the complex I assembly factor TIMMDC1 establishing a novel disease-associated gene. In conclusion, our study expands the diagnostic tools for detecting non-exonic variants and provides examples of intronic loss-of-function variants with pathological relevance.

22 December 2011 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
OBOlivia Boyer
Olivia Boyer
FNFabien Nevo
Fabien Nevo
EPEmmanuelle Plaisier
Emmanuelle Plaisier
BFBenoit Funalot
Benoit Funalot
OGOlivier Gribouval
Olivier Gribouval
GMGéraldine Mollet
Géraldine Mollet
Charcot–Marie–Tooth neuropathy has been reported to be associated with renal diseases, mostly focal segmental glomerulosclerosis (FSGS). However, the common mechanisms underlying the neuropathy and FSGS remain unknown. Mutations in INF2 were recently identified in patients with autosomal dominant FSGS. INF2 encodes a formin protein that interacts with the Rho-GTPase CDC42 and myelin and lymphocyte protein (MAL) that are implicated in essential steps of myelination and myelin maintenance. We therefore hypothesized that INF2 may be responsible for cases of Charcot–Marie–Tooth neuropathy associated with FSGS.

5 November 2009 in Human Mutation
Verified
Journal Article
Open access
PDF file
VLV. Laugel
V. Laugel
CDC. Dalloz
C. Dalloz
MDM. Durand
M. Durand
FSF. Sauvanaud
F. Sauvanaud
UKU. Kristensen
U. Kristensen
HDH. Dollfus
H. Dollfus
Cockayne syndrome is an autosomal recessive multisystem disorder characterized principally by neurological and sensory impairment, cachectic dwarfism, and photosensitivity. This rare disease is linked to mutations in the CSB/ERCC6 and CSA/ERCC8 genes encoding proteins involved in the transcription‐coupled DNA repair pathway. The clinical spectrum of Cockayne syndrome encompasses a wide range of severity from severe prenatal forms to mild and late‐onset presentations. We have reviewed the 45 published mutations in CSA and CSB to date and we report 43 new mutations in these genes together with the corresponding clinical data. Among the 84 reported kindreds, 52 (62%) have mutations in the CSB gene. Many types of mutations are scattered along the whole coding sequence of both genes, but clusters of missense mutations can be recognized and highlight the role of particular motifs in the proteins. Genotype–phenotype correlation hypotheses are considered with regard to these new molecular and clinical data. Additional cases of molecular prenatal diagnosis are reported and the strategy for prenatal testing is discussed. Two web‐based locus‐specific databases have been created to list all identified variants and to allow the inclusion of future reports (www.umd.be/CSA/ and www.umd.be/CSB/). Hum Mutat 31:113–126, 2010.

1 January 2009 in Amyotrophic Lateral Sclerosis
Verified
Journal Article
Closed access
BFBenoit Funalot
Benoit Funalot
JDJean-Claude Desport
Jean-Claude Desport
Franck SturtzFranck Sturtz
Franck Sturtz
WCWilliam Camu
William Camu
PCPhilippe Couratier
Philippe Couratier
An abnormally elevated level of resting energy expenditure (REE, measured by indirect calorimetry) has been reported in a subset of patients with sporadic amyotrophic lateral sclerosis (SALS). Hypermetabolism (measured REE/calculated REE (cREE)> or =1.1, or 110%) has also been observed in transgenic mice harbouring ALS-causing mutations in the SOD1 gene. By contrast, the REE of patients with familial amyotrophic lateral sclerosis (FALS) has never been assessed. Our objective was to evaluate the metabolic and nutritional parameters of FALS patients and to compare them with those of SALS patients, and search for correlations with clinical parameters. Eleven patients with FALS (from 10 different families, none carrying a SOD1 mutation) were evaluated by indirect calorimetry in our centre. As a control group, we used a sample of 33 patients with SALS, matched for age and sex with the FALS patients. 11/11 (100%) patients with FALS were hypermetabolic, compared to 17/33 (52%) patients with SALS (p=0.009). Measured REE (mREE) and mREE/cREE (metabolic level) were significantly higher in FALS patients than in SALS patients (p=0.03 and p=0.0008, respectively). No correlation was found between metabolic measures and neurological or respiratory parameters. In conclusion, hypermetabolism appears to be a common feature of subjects with FALS, suggesting that this impairment of energy homeostasis may be genetically driven. The high metabolic level of FALS patients should be taken into account for their nutritional management (need for a high-energy diet to prevent malnutrition).

1 May 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SGSylvie Gerber
Sylvie Gerber
KAKamil J. Alzayady
Kamil J. Alzayady
LBLydie Burglen
Lydie Burglen
DBDominique Brémond-Gignac
Dominique Brémond-Gignac
VMValentina Marchesin
Valentina Marchesin
LTLucas FARES TAIE
Lucas FARES TAIE

1 December 2014 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
ECEstelle Colin
Estelle Colin
ECEvelyne Huynh Cong
Evelyne Huynh Cong
GMGéraldine Mollet
Géraldine Mollet
AGAgnès Guichet
Agnès Guichet
OGOlivier Gribouval
Olivier Gribouval
CACorinne Antignac
Corinne Antignac